Post-Grant Review Petitioner: Cancer Treatment Patent Is Obvious
ALEXANDRIA, Va. — In a Nov. 11 petitioner reply filed with the Patent Trial and Appeal Board, a petitioner for post-grant review (PGR) of a cancer treatment patent maintains its position...To view the full article, register now.
Already a subscriber? Click here to view full article